Israel Englander’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Israel Englander’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,739	Closed	-$231K	–	4027
2016 Q3	$231K	Sell	5,739 -40,410	-88%	-$998K	﹤0.01%	2923
2016 Q2	$773K	Sell	46,149 -191,227	-81%	-$2.57M	﹤0.01%	2288
2016 Q1	$2.83M	Sell	237,376 -24,326	-9%	-$326K	0.01%	1595
2015 Q4	$4M	Sell	261,702 -12,500	-5%	-$190K	0.01%	1510
2015 Q3	$4.43M	Sell	274,202 -13,188	-5%	-$214K	0.01%	1413
2015 Q2	$4.68M	Buy	+287,390	New	+$4.71M	0.01%	1442

Israel Englander's CYNA Position: Q4 2016 in Review

Israel Englander sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 5,739 shares — an estimated $231K sold.

Israel Englander first reported a position in CYNA in Q2 2015 and held it in 6 quarters. The position peaked at $4.68M in Q2 2015. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Israel Englander reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Israel Englander sold 5,739 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $231K.
Israel Englander first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 6 quarters.
Israel Englander's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $4.68M in Q2 2015.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.